Cargando…
Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
Current efforts to find novel treatments that counteract multiple sclerosis (MS) have pointed toward immunomodulation and remyelination. Currently, cell therapy has shown promising potential to achieve this purpose. However, disadvantages such as poor survival, differentiation, and integration into...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504193/ https://www.ncbi.nlm.nih.gov/pubmed/36143453 http://dx.doi.org/10.3390/life12091417 |
_version_ | 1784796154200850432 |
---|---|
author | Ojeda-Hernández, Doddy Denise Hernández-Sapiéns, Mercedes A. Reza-Zaldívar, Edwin E. Canales-Aguirre, Alejandro Matías-Guiu, Jordi A. Matías-Guiu, Jorge Mateos-Díaz, Juan Carlos Gómez-Pinedo, Ulises Sancho-Bielsa, Francisco |
author_facet | Ojeda-Hernández, Doddy Denise Hernández-Sapiéns, Mercedes A. Reza-Zaldívar, Edwin E. Canales-Aguirre, Alejandro Matías-Guiu, Jordi A. Matías-Guiu, Jorge Mateos-Díaz, Juan Carlos Gómez-Pinedo, Ulises Sancho-Bielsa, Francisco |
author_sort | Ojeda-Hernández, Doddy Denise |
collection | PubMed |
description | Current efforts to find novel treatments that counteract multiple sclerosis (MS) have pointed toward immunomodulation and remyelination. Currently, cell therapy has shown promising potential to achieve this purpose. However, disadvantages such as poor survival, differentiation, and integration into the target tissue have limited its application. A series of recent studies have focused on the cell secretome, showing it to provide the most benefits of cell therapy. Exosomes are a key component of the cell secretome, participating in the transfer of bioactive molecules. These nano-sized vesicles offer many therapeutical advantages, such as the capacity to cross the blood-brain barrier, an enrichable cargo, and a customizable membrane. Moreover, integrating of biomaterials into exosome therapy could lead to new tissue-specific therapeutic strategies. In this work, the use of exosomes and their integration with biomaterials is presented as a novel strategy in the treatment of MS. |
format | Online Article Text |
id | pubmed-9504193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95041932022-09-24 Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis Ojeda-Hernández, Doddy Denise Hernández-Sapiéns, Mercedes A. Reza-Zaldívar, Edwin E. Canales-Aguirre, Alejandro Matías-Guiu, Jordi A. Matías-Guiu, Jorge Mateos-Díaz, Juan Carlos Gómez-Pinedo, Ulises Sancho-Bielsa, Francisco Life (Basel) Review Current efforts to find novel treatments that counteract multiple sclerosis (MS) have pointed toward immunomodulation and remyelination. Currently, cell therapy has shown promising potential to achieve this purpose. However, disadvantages such as poor survival, differentiation, and integration into the target tissue have limited its application. A series of recent studies have focused on the cell secretome, showing it to provide the most benefits of cell therapy. Exosomes are a key component of the cell secretome, participating in the transfer of bioactive molecules. These nano-sized vesicles offer many therapeutical advantages, such as the capacity to cross the blood-brain barrier, an enrichable cargo, and a customizable membrane. Moreover, integrating of biomaterials into exosome therapy could lead to new tissue-specific therapeutic strategies. In this work, the use of exosomes and their integration with biomaterials is presented as a novel strategy in the treatment of MS. MDPI 2022-09-11 /pmc/articles/PMC9504193/ /pubmed/36143453 http://dx.doi.org/10.3390/life12091417 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ojeda-Hernández, Doddy Denise Hernández-Sapiéns, Mercedes A. Reza-Zaldívar, Edwin E. Canales-Aguirre, Alejandro Matías-Guiu, Jordi A. Matías-Guiu, Jorge Mateos-Díaz, Juan Carlos Gómez-Pinedo, Ulises Sancho-Bielsa, Francisco Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis |
title | Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis |
title_full | Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis |
title_fullStr | Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis |
title_full_unstemmed | Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis |
title_short | Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis |
title_sort | exosomes and biomaterials: in search of a new therapeutic strategy for multiple sclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504193/ https://www.ncbi.nlm.nih.gov/pubmed/36143453 http://dx.doi.org/10.3390/life12091417 |
work_keys_str_mv | AT ojedahernandezdoddydenise exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT hernandezsapiensmercedesa exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT rezazaldivaredwine exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT canalesaguirrealejandro exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT matiasguiujordia exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT matiasguiujorge exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT mateosdiazjuancarlos exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT gomezpinedoulises exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis AT sanchobielsafrancisco exosomesandbiomaterialsinsearchofanewtherapeuticstrategyformultiplesclerosis |